vTv Therapeutics Inc.

NASDAQ:VTVT

14 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 01-0.00900.00900.00900.00920.00930.0090.9876.3990.00700.0080.0070.0081.8280.9214.5223.3752.4732.0640.2330.0150.0130.030.0380.0380.1820.3760.2260.1330.110.050.9340.40.2010.014
Cost of Revenue 0.0230.0220.0230.0220.0230.0220.0230.0240.0880.0230.0052.3822.4373.1032.5341.7682.5094.2044.4063.6634.2282.8222.82.6988.5948.94310.0688.9899.62310.9611.09911.16512.14911.3358.9467.1595.7027.7765.4624.3284.5354.404
Gross Profit -0.0230.978-0.032-0.022-0.014-0.022-0.014-0.024-0.0791.9770.0040.618-2.428-2.1163.865-1.761-2.509-4.196-4.399-3.655-2.4-1.9011.7220.677-6.121-6.879-9.835-8.974-9.61-10.93-11.061-11.127-11.967-10.959-8.72-7.026-5.592-7.726-4.528-3.928-4.334-4.39
Gross Profit Ratio 00.9783.5560-1.5560-1.5560-8.7780.9890.4450.206-269.778-2.1440.604-251.5710-524.5-628.429-456.875-1.313-2.0640.3810.201-2.475-3.333-42.21-598.267-739.231-364.333-291.079-292.816-65.753-29.146-38.584-52.827-50.836-154.52-4.848-9.82-21.562-313.571
Reseach & Development Expenses 3.4162.6272.1152.8244.6913.9423.9643.0552.2053.1335.4022.3822.4373.1032.5341.7682.5094.2044.4063.6634.2282.8222.82.6988.5948.94310.0688.9899.62310.9611.09911.16512.14911.3358.9467.1595.7027.7765.4624.3284.5354.404
General & Administrative Expenses 3.7163.9782.5692.5443.3093.4852.3882.6341.8315.3485.7162.2212.2422.1642.0351.0711.6952.451.9891.772.3922.3862.0732.1582.7372.2552.9372.5673.0052.8242.2522.4012.6722.5812.372.4152.2971.9952.141.5922.8585.127
Selling & Marketing Expenses 000000000000000000000000000000000000000000
SG&A 3.7163.9782.5692.5443.3093.4852.3882.6341.8315.3485.7162.2212.2422.1642.0351.0711.6952.451.9891.772.3922.3862.0732.1582.7372.2552.9372.5673.0052.8242.2522.4012.6722.5812.372.4152.2971.9952.141.5922.8585.127
Other Expenses 0.193-0.3710.185-3.2990.6381.5530.1070.079-0.114-2.7421.63200-1.648-0.1560.814-0.565-0.363-0.223-0.1460.2760.921-1.2480.3290.3160.011-0.19000-0.0240.0020.001-0.0010.031-0.381-1.6780.492-0.649-0.147-0.151-0.179
Operating Expenses 7.1326.6054.6845.36887.4276.3525.6894.0368.48111.1184.6034.6795.2674.5692.8394.2046.6546.3955.4336.625.2084.8734.85611.33111.19813.00511.55612.62813.78413.35113.56614.82113.91611.3169.5747.9999.7717.6025.927.3939.531
Operating Income -7.155-5.627-4.707-6.654-8-7.427-6.343-5.689-4.027-6.481-11.109-1.603-4.67-4.281.83-2.832-4.204-6.646-6.388-5.425-4.792-4.287-0.351-1.481-8.858-9.134-12.772-11.541-12.615-13.754-13.313-13.528-14.639-13.54-11.09-9.441-7.889-9.721-6.668-5.52-7.192-9.517
Operating Income Ratio 0-5.6275230-888.8890-704.7780-447.444-3.241-1,234.333-0.534-518.889-4.3360.286-404.5710-830.75-912.571-678.125-2.621-4.655-0.078-0.439-3.582-4.425-54.815-769.4-970.385-458.467-350.342-356-80.434-36.011-49.071-70.985-71.718-194.42-7.139-13.8-35.781-679.786
Total Other Income Expenses Net 0.746-0.2920.266-3.2990.6381.6530.2530.221-0.064-2.7431.6320.2443.829-1.648-0.1560.814-0.565-0.363-0.223-0.1460.2760.921-1.2480.3290.3160.011-0.19-0.814-0.799-0.532-0.0240.0020.001-0.0010.031-0.381-1.6780.492-0.709-0.147-0.156-0.183
Income Before Tax -6.409-5.919-4.441-6.654-7.211-5.774-6.09-5.468-4.091-9.224-9.483-1.365-0.841-5.9271.607-2.253-4.991-7.165-6.882-5.96-5.014-3.982-2.328-1.961-9.396-9.96-13.792-12.355-13.414-14.286-13.711-13.505-14.617-13.52-11.059-9.822-10.412-9.813-7.715-5.87-7.404-15.112
Income Before Tax Ratio 0-5.919493.4440-801.2220-676.6670-454.556-4.612-1,053.667-0.455-93.444-6.0050.251-321.8570-895.625-983.143-745-2.743-4.324-0.515-0.581-3.799-4.826-59.193-823.667-1,031.846-476.2-360.816-355.395-80.313-35.957-48.934-73.85-94.655-196.26-8.26-14.675-36.836-1,079.429
Income Tax Expense -1.2290.1-0.963-3.321-0.952-1.275-0.2-1.207-0.940.2-0.1150.1-0.2330.0150.370.329-1.966-2.636-2.438-2.1020.1-0.28-1.849-0.0140.2-6.1420.8-8.67-9.418-10.039-39.001-9.533-10.159-9.669-8.03-5.719-0.8331.076-0.3110.056-0.0955.233
Net Income -5.18-4.865-3.478-6.654-5.619-4.499-5.89-4.261-3.151-9.424-7.051-1.087-0.608-4.2411.126-1.533-3.368-4.724-4.399-3.608-2.882-2.155-1.091-0.796-3.072-2.952-4.311-3.65-3.963-4.22-4.05-3.993-4.457-3.852-3.169-4.103-10.412-9.813-7.715-5.87-7.404-15.112
Net Income Ratio 0-4.865386.4440-624.3330-654.4670-350.111-4.712-783.444-0.362-67.556-4.2970.176-2190-590.5-628.429-451-1.577-2.34-0.241-0.236-1.242-1.43-18.502-243.333-304.846-140.667-106.579-105.079-24.489-10.245-14.022-30.85-94.655-196.26-8.26-14.675-36.836-1,079.429
EPS -0.81-1.17-1.67-3.27-2.76-2.21-2.89-2.12-1.79-5.63-4.22-0.71-0.41-30.88-1.27-2.95-4.35-4.64-4.49-4.11-3.77-2.47-2.59-12.23-12.17-17.79-15.06-16.35-17.41-16.71-16.48-18.64-16.69-13.84-19.76-50.15-47.26-37.16-28.57-36.03-73.54
EPS Diluted -0.81-1.17-1.67-3.27-2.76-2.21-2.89-2.12-1.79-5.63-4.22-0.71-0.41-30.61-1.27-2.95-4.35-4.64-4.49-4.11-3.77-2.47-2.59-12.23-12.17-17.79-15.06-16.35-17.41-16.71-16.48-18.64-16.69-13.84-19.76-50.15-47.26-37.16-28.57-36.03-73.54
EBITDA -7.132-5.605-4.684-6.654-7.186-5.752-6.084-5.436-4.069-9.2-9.477-1.581-4.648-5.9041.674-1.995-4.747-6.97-6.599-5.556-4.492-3.348-1.585-1.109-8.487-9.063-12.94-11.458-12.53-13.675-13.317-13.46-14.548-13.441-11.09-9.441-9.453-9.096-7.134-5.439-7.127-9.459
EBITDA Ratio 0-5.605520.4440-798.4440-6760-452.111-4.6-1,053-0.527-516.444-5.9820.262-2850-871.25-942.714-694.5-2.457-3.635-0.351-0.329-3.432-4.391-55.536-763.867-963.846-455.833-350.447-354.211-79.934-35.747-49.071-70.985-85.936-181.92-7.638-13.598-35.458-675.643